CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

AGFA HealthCare Corporation

AGFA HealthCare Corporation is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

South County Hospital

South County Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. South County Hospital is based in Wakefield, RI. You can find more information on South County Hospital at www.schospital.com

American Competitiveness Institute

American Competitiveness Institute is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ROWI

ROWI Teen is a mental health treatment center for teens and adolescents, specializing in mental health issues like depression, anxiety, OCD, and ASD.

Curve Health

Curve Health is senior care without walls. Founded in April of 2020 on a platform that`s reduced patient transfers from Skilled Nursing Facilities (SNFs) to Emergency Departments by 50%+, Curve advances connected senior care by bridging the silos that hinder healthcare delivery today; enabling physicians to remotely care for patients in SNFs, at home, in ambulances or wherever they may be. Curve combines telemedicine, a health information exchange, predictive analytics and smart billing into a single platform, resulting in higher quality care + significant return on investment, while ensuring the most seamless patient experience.